Breast cancer is one of the leading causes of cancer mortality, with incidence, pathology, and clinical outcomes varying by geographical distribution as well as different racial and ethnic populations. Black, compared to White women with localized breast cancer have higher mortality and worse distant recurrence-free survival, which is often attributed to social determinants of health and higher prevalence of triple-negative breast cancer in black patients. In addition, racial and ethnic diversity in breast cancer clinical trials is lacking with both Blacks and Hispanics underrepresented.

In this podcast, we hear from Yara Abdou, MD, UNC School of Medicine, Chapel Hill, NC, Maja H. Oktay, MD, PhD, Montefiore Einstein Cancer Center, Bronx, NY, and Neelima Vidula, MD, Massachusetts General Hospital, Boston, MA, who discuss the impact of race on breast cancer outcomes, with respect to the RxPONDER trial, the role of the tumor microenvironment, as well as the impact of race on clinical, socioeconomic, and genomic characteristics, clinical trial participation, and receipt of genotype-matched therapy among patients with metastatic breast cancer.

The Breast Cancer Podcasts on VJOncology are supported by Seagen. Seagen have no influence over the production of the content.